Latest News
Sygnature have acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein ...
Financing led by new investors, GV, Northpond Ventures and Sanofi Ventures, with existing investors, Syncona, Oxford Science Enterprises, and Oxford ...
BioCity Nottingham-based marketing and PR agency V Formation is celebrating its fifteenth birthday amidst sustained growth and new plans for ...
BioCity, Scotland, 26th April 2022 Invizius Limited (“Invizius”), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today ...
The Wilton Centre continues to be a magnet to companies wanting to be a part of the green industrial revolution ...
Cellomatics Biosciences, based at BioCity Nottingham has today been recognised with one of the UK’s most prestigious business awards – the Queen’s ...
Nottingham-based contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions, has launched a unique nasal delivery development platform, UpperNose™, to ...
Boom in start-ups and spin-outs drives growth for UK life sciences as investment almost doubles New report shows number of ...
A programme designed to help promising start-ups commercialise drug discovery and provide access to much-needed laboratory space 2021 was the ...
